CBDV (Cannabidivarin): Two Carbons Shorter Than CBD

Why does one cannabinoid get an extra letter?

CBDV is short for cannabidivarin. It sits in the same group of plant cannabinoids as CBD, CBG, CBC and CBN, and like them it is non-intoxicating. The chemical literature gives it a tighter description: the propyl analogue of cannabidiol [1]. Analogue means near-copy. Same blueprint, one piece shortened.

Which piece? The side chain hanging off the ring system. Everything else lines up. The ring system is identical in both molecules, the double bonds sit in the same positions, and the hydroxyl groups are exactly where you would find them on CBD [1]. Draw the two structures side by side and the difference appears at one end of the molecule and nowhere else on the page.

That is the whole content of the extra letter. Not a different class of compound. Not a different plant. A shorter tail on something that is otherwise CBD, right down to the placement of the oxygen atoms. Worth saying plainly, because a V in a cannabinoid name tends to get read as something rare and exotic when it is really a note about length.

• Class: a plant cannabinoid, the same family as CBD, CBG, CBC and CBN [1].
• Status: non-intoxicating, as recorded in the chemical literature on cannabis constituents [1].
• Formal name in chemistry: the propyl analogue of cannabidiol [1].
• Shared with CBD: ring system, double bond positions, hydroxyl groups [1].
• Not shared with CBD: the length of the side chain, and nothing beyond that.

How the "-varin" ending works

Chemical surveys of the plant have turned up propyl counterparts for several of the pentyl cannabinoids [1]. Rather than invent a new name each time, the literature uses a suffix. Where you see "-varin" at the end, you are looking at the version with the shorter chain.

Pentyl means a five-carbon chain. Propyl means three. Two carbons is the entire distance between the two names, and the pairing is structural bookkeeping more than anything else. Knowing that CBDV is the propyl form of CBD tells you how to draw it. It says nothing about what either molecule does in a body, and the cited surveys do not stretch that far either.

The same rule runs across the other well-known pair, which is why the naming is worth learning once instead of looking up twice.

• CBD: a pentyl side chain, five carbons, the reference molecule for this pair.
• CBDV: a propyl side chain, three carbons, the varin form of that same structure.
• THC: a pentyl side chain, five carbons, following the identical convention.
• THCV: a propyl side chain, three carbons, and again a V doing the work of the word "shorter".

From precursor to propyl: where the split happens

1. An enzyme out of hemp. Fellermeier and Zenk's 1998 work described a prenyltransferase from the plant [2]. A prenyltransferase is simply an enzyme that attaches a prenyl unit to a second molecule, and here it performs the joining step that starts the cannabinoid line.
2. Two starting materials. The reaction brings together geranyl pyrophosphate on one side and olivetolic acid on the other [2]. Both names look forbidding and both are ordinary plant building blocks.
3. One product. What comes out is cannabigerolic acid, written CBGA, and it acts as the common acid precursor of the pentyl cannabinoids [2].
4. Dated to the late 1990s. That main line was mapped in those years, which is why CBGA shows up as the reference point in almost every diagram of hemp chemistry drawn since.
5. Swap one substrate. Put a resorcinolic acid carrying a three-carbon chain into the position olivetolic acid would normally occupy [2].
6. Same step, different output. The prenylation proceeds in the same way, and the result is cannabigerovarinic acid, CBGVA, instead of CBGA [2].
7. Length is set early. Reading the cited work, the short tail is already in place at the acid stage. The plant does not trim a pentyl cannabinoid down to a propyl one later, which is the tidiest way to remember why varins form a group of their own.

How much of it is actually there

CBDV appears among the cannabinoids identified in cannabis surveys, so its presence is not in question [1]. The quantity is the interesting part. Taken as a group, the varins are typically recorded at concentrations well below the pentyl cannabinoids [1]. Present, measurable, small.

Physically it behaves like its relatives. CBDV is lipophilic, meaning it dissolves in fats and oils rather than water, and its water solubility is poor. In practice it travels along with the rest of the profile through standard CO2 extraction, without any step that singles it out.

So a full-spectrum extract can carry it, in the same proportion the plant material offered in the first place.

What that means for our range

No Cibdol product is built around CBDV. We have been working with cannabinoids since 2014, and the rule we set then still applies: what goes on the label is what the batch analysis can support. A trace constituent that varies with the plant does not become a headline compound because the name sounds interesting. If that changes, the report will say so before the marketing does.

Reading CBDV on a batch analysis

1. Match the two names. Cannabidivarin and CBDV are one entry, not two. A report that lists both is repeating itself.
2. Check the panel. Some analyses cover only the pentyl cannabinoids. If propyl forms are not on the list of tested compounds, their absence from the results is a gap in the method, not a finding about the extract.
3. Expect small figures. Varins as a group sit well below the pentyl cannabinoids in cannabis surveys [1], so a large CBDV number deserves a second look at the method.
4. Keep the lines separate. CBDV and CBD belong to the same class and both are non-intoxicating [1], and they are still two different molecules on two different rows.
5. Note the extraction. Because CBDV is lipophilic and barely soluble in water, it comes along with the oil-soluble fraction of a standard CO2 extract rather than being isolated.
6. Ask who measured it. The useful answer is an independent analysis tied to a specific batch, which is the same document we have pointed people to since 2014.